FTC Probing Alcon's $430M Lensar Deal
By Matthew Perlman · May 23, 2025, 5:40 PM EDT
The Federal Trade Commission has requested additional information about Swiss eye care company Alcon Inc.'s planned purchase of Florida-based medical technology developer Lensar Inc. in a deal worth up to $430...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login